top of page
Revolutionary nanomedicines
to heal ophthalmological disorders
We are a pre-clinical biotechnology start-up company developing novel lipopeptide sequences that self-assemble into nanostructures for sustained delivery of neuropeptides, ions and mRNAs.
Primary open-angle glaucoma as lead indication
Product
bottom of page